Antihyperglycemic, Vasodilator, and Diuretic Activities of Microencapsulated Bioactive Product from Moringa stenopetala Leaves Extract
Table 2
Antihyperglycemic effects of microencapsulated bioactive product of M. stenopetala leaves extract.
Treatment groups
Fastened blood glucose level (mg/dl)
1st day
7th day
14th day
21st day
Dose 500 mg/kg
337.60 ± 63.93aA
329.90 ± 65.33aB
319.90 ± 68.30aB
281.80 ± 67.05aB
Dose 750 mg/kg
271.10 ± 35.86aA
257.40 ± 37.60aAB
241.60 ± 37.32aAB
228.20 ± 33.80aAB
Dose 1000 mg/kg
300.20 ± 47.94aA
263.60 ± 29.50aAB
258.90 ± 48.17aA
242.00 ± 47.41aAB
Positive control
291.90 ± 51.95aA
265.70 ± 51.07aA
248.00 ± 49.03aA
221.70 ± 48.08aA
Negative control
223.90 ± 37.59b
316.20 ± 31.68a
330.70 ± 24.11a
347.10 ± 36.06a
Normal control
99.00 ± 5.70a
99.20 ± 6.72aC
98.20 ± 5.54aC
98.20 ± 5.81a
Superscript letters with small letters indicate the presence of significant differences () in a raw (in different days), whereas the capital letters indicate the presence of significant differences in a column (different doses of the microencapsulates and control groups).